Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramOfficers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 16 | Stetz MattiasChief Operating Officer | Open-market sale · 10b5-1 plan | SELL | $353K 20.0K sh |
| Feb 4, 2026 traded Feb 2, 2026 |
| 16 | Moshkevich SolomonPRESIDENT, CLINICALDIAGNOSTICS | Open-market sale · 10b5-1 plan | SELL | $197K 850 sh | Feb 4, 2026 traded Feb 2, 2026 |
| 16 | Smith NathanChief Financial Officer | Tax withholding | F | $79K 3,859 sh | Feb 4, 2026 traded Feb 2, 2026 |
| 16 | Kleczynski Robert ASVP, Controller & Tax | Disposition to issuer | D | $218K 4,963 sh | Feb 4, 2026 traded Feb 2, 2026 |
| 16 | Moshkevich SolomonPRESIDENT, CLINICALDIAGNOSTICS | Open-market sale · 10b5-1 plan | SELL | $140K 600 sh | Feb 4, 2026 traded Feb 2, 2026 |
| 16 | Frost DianaDirector | Tax withholding | F | $57K 548 sh | Feb 4, 2026 traded Feb 2, 2026 |
| 16 | Clark Kyra ESenior Vice President | Tax withholding | F | $63K 1,045 sh | Feb 4, 2026 traded Feb 2, 2026 |
| 15 | Munari Alvise J.Chief Product Officer | Tax withholding | F | $274K 438 sh | Feb 4, 2026 traded Feb 2, 2026 |
| 15 | White Daniel JamesDirector | Grant or award | A | $27K 818 sh | Feb 4, 2026 traded Jan 28, 2026 |
| 15 | Furbee DanielDirector, SEE REMARKS | Option exercise | M | — 51.6K sh | Feb 4, 2026 traded Feb 1, 2026 |
| 15 | Frew JamesSEE REMARKS | Option exercise | M | — 50.6K sh | Feb 4, 2026 traded Feb 1, 2026 |
| 15 | Jahnel DarrinDirector | Grant or award | A | $2,238 69 sh | Feb 4, 2026 traded Jan 28, 2026 |
| 15 | Zalenko Neal F.Director | Small acquisition | L | $6,350 588 sh | Feb 4, 2026 traded Jan 27, 2026 |
| 15 | Dawsey James MDirector | Grant or award | A | $27K 818 sh | Feb 4, 2026 traded Jan 28, 2026 |
| 15 | France NatashaSEE REMARKS | Tax withholding | F | $16K 3,100 sh | Feb 4, 2026 traded Feb 1, 2026 |
| 13 | Lee CindyChief Financial Officer | Tax withholding | F | — 1,108 sh | Feb 4, 2026 traded Feb 2, 2026 |
| 13 | Sharma ManishChief Strategy & Services Ofcr | Open-market sale · 10b5-1 plan | SELL | $25K 98 sh | Feb 4, 2026 traded Feb 3, 2026 |
| 13 | Meng JessicaChief Commercial Officer | Grant or award | A | — 11.6K sh | Feb 4, 2026 traded Feb 2, 2026 |
| 13 | Cooke Malcolm G.VP, Chief Info Tech Officer | Tax withholding | F | $37K 6,658 sh | Feb 4, 2026 traded Feb 2, 2026 |
| 13 | Parker Stuart B.Director | Grant or award | A | — 1,263 sh | Feb 4, 2026 traded Feb 2, 2026 |
| 13 | Lee CindyChief Financial Officer | Option exercise | M | — 2,749 sh | Feb 4, 2026 traded Feb 2, 2026 |
| 13 | Robinson-Gay DonaldSenior Vice President | Grant or award | A | — 1,275 sh | Feb 4, 2026 traded Feb 2, 2026 |
| 13 | Jones Jeanne MEVP, CFO, Audit & Risk | Option exercise | M | — 6,485 sh | Feb 4, 2026 traded Feb 2, 2026 |
| 13 | Jones Jeanne MEVP, CFO, Audit & Risk | Option exercise | M | — 5,197 sh | Feb 4, 2026 traded Feb 2, 2026 |
| 13 | Clark Kyra ESenior Vice President | Grant or award | A | — 1,802 sh | Feb 4, 2026 traded Feb 3, 2026 |
| 13 | Lobred AnnMarie M.See Remarks | Tax withholding | F | $29K 331 sh | Feb 4, 2026 traded Feb 3, 2026 |
| 13 | Howze YalondaINTERIM CEO & PRESIDENT | Tax withholding | F | $2,792 495 sh | Feb 4, 2026 traded Feb 2, 2026 |
| 13 | Moshkevich SolomonPRESIDENT, CLINICALDIAGNOSTICS | Open-market sale · 10b5-1 plan | SELL | $3,744 16 sh | Feb 4, 2026 traded Feb 2, 2026 |
| 13 | Conway Kevin JohnChief Financial Officer | Option exercise | M | — 235 sh | Feb 4, 2026 traded Feb 2, 2026 |
| 13 | Russotti GregorySee Remarks | Grant or award | A | — 135.0K sh | Feb 4, 2026 traded Feb 2, 2026 |
| 13 | Gutman CarrieSenior Vice President | Tax withholding | F | $20K 321 sh | Feb 4, 2026 traded Feb 2, 2026 |
| 13 | Kleczynski Robert ASVP, Controller & Tax | Option exercise | M | — 7,019 sh | Feb 4, 2026 traded Feb 2, 2026 |
| 13 | Novack Jeffrey AdamSecretary and General Counsel | Grant or award | A | — 33.0K sh | Feb 4, 2026 traded Feb 2, 2026 |
| 13 | Wampler Kira SchererDirector | Open-market sale · 10b5-1 plan | SELL | $75K 2,000 sh | Feb 4, 2026 traded Feb 2, 2026 |
| 13 | Smith NathanChief Financial Officer | Grant or award | A | — 7,875 sh | Feb 4, 2026 traded Feb 2, 2026 |
| 13 | Quigley AdamChief Financial Officer | Grant or award | A | $18K 190 sh | Feb 4, 2026 traded Feb 2, 2026 |
| 13 | Biebuyck OlivierPresident, Fab Tech | Option exercise | M | — 1,232 sh | Feb 4, 2026 traded Feb 2, 2026 |
| 13 | Lee CindyChief Financial Officer | Option exercise | M | — 2,749 sh | Feb 4, 2026 traded Feb 2, 2026 |
| 13 | Carr DouglasSVP Finance & Operations | Grant or award | A | — 110.0K sh | Feb 4, 2026 traded Feb 2, 2026 |
| 13 | Lee CindyChief Financial Officer | Tax withholding | F | — 1,246 sh | Feb 4, 2026 traded Feb 3, 2026 |